Peterlabs Holdings Bhd (XKLS:0171) Research & Development: RM0.0 Mil (TTM As of Jun. 2025)


XKLS:0171 Peterlabs Holdings Bhd XKLS:0171
47 GF Score
Price RM0.24
GF Value RM0.20
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Peterlabs Holdings Bhd Research & Development?

Peterlabs Holdings Bhd XKLS:0171 47 Research & Development is RM0.0 Mil as of Jun. 2025. GuruFocus rates XKLS:0171 with a GF Score™ of 47/100 and a GF Value™ of RM0.20 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Peterlabs Holdings Bhd's Research & Development for the three months ended in Jun. 2025 was RM0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was RM0.0 Mil.

Peterlabs Holdings Bhd  (XKLS:0171) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Peterlabs Holdings Bhd Research & Development Related Terms

Peterlabs Holdings Bhd Research & Development Historical Data

* Premium members only.

The historical data trend for Peterlabs Holdings Bhd's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peterlabs Holdings Bhd Research & Development Chart

Peterlabs Holdings Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Peterlabs Holdings Bhd Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XKLS:0171
47GF Score
Peterlabs Holdings Bhd XKLS:0171
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Peterlabs Holdings Bhd Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of RM0.0 Mil mean?
Peterlabs Holdings Bhd (XKLS:0171) has a Research & Development of RM0.0 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on Peterlabs Holdings Bhd and its competitors.
Is Peterlabs Holdings Bhd's Research & Development too high?
Peterlabs Holdings Bhd's current Research & Development is RM0.0 Mil. Overall, Peterlabs Holdings Bhd has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Peterlabs Holdings Bhd's Research & Development compare to ZTS and UTHR?
Peterlabs Holdings Bhd's Research & Development of RM0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Peterlabs Holdings Bhd and its competitors. Peterlabs Holdings Bhd's current Research & Development is RM0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peterlabs Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Peterlabs Holdings Bhd (XKLS:0171) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.20, compared to a current price of RM0.24 — trading 17.5% above its estimated fair value. The current Research & Development is RM0.0 Mil. Peterlabs Holdings Bhd's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Peterlabs Holdings Bhd (XKLS:0171), the current Research & Development is RM0.0 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Peterlabs Holdings Bhd (XKLS:0171) Overvalued in 2026?

Based on GuruFocus' analysis, Peterlabs Holdings Bhd stock appears to be overvalued. The current stock price of RM0.24 is trading 17.5% above its estimated GF Value™ of RM0.20. GuruFocus considers Peterlabs Holdings Bhd to be Modestly Overvalued.

Key valuation signals for XKLS:0171:

  • Research & Development: RM0.0 Mil
  • GF Value™: RM0.20 vs. price of RM0.24 (17.5% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the XKLS:0171 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Peterlabs Holdings Bhd Business Description

Address Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800
Peterlabs Holdings Bhd is engaged in the manufacturing, distribution, export, and trading of animal health and nutrition products. The Group offers biosecurity and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements, as well as farm management, technical advisory services, raw material analysis, and feed formulation. Its segments are Manufacturing, which covers the manufacturing and distribution of animal health and nutrition products; Trading, which involves the trading and distribution of animal health and nutrition products and consumer goods, and contributes the majority of its revenue; and Others, which provides investment holding services. The company operates in Malaysia and internationally.
47GF Score

Get the complete analysis for XKLS:0171

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.24
Price
RM0.20
GF Value